Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Isotretinoin 20mg capsules
1306020J0AAABAB
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 3,788 |
|
Isotretinoin 10mg capsules
1306020J0AAACAC
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 1,388 |
|
Roaccutane 20mg capsules
1306020J0BBABAB
|
Roaccutane | Isotretinoin | Skin | 402 |
|
Roaccutane 10mg capsules
1306020J0BBACAC
|
Roaccutane | Isotretinoin | Skin | 141 |
|
Isotretinoin 5mg capsules
1306020J0AAAAAA
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 136 |
|
Isotretinoin 40mg capsules
1306020J0AAAEAE
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 55 |
|
Isotretinoin 0.05% gel
1306010M0AAAAAA
|
Isotretinoin (Topical) | Isotretinoin | Skin | 2 |
|
Isotretinoin 20mg tablets
1306020J0AAADAD
|
Isotretinoin (Systemic) | Isotretinoin | Skin | No data available |
|
Isotrex 0.05% gel
1306010M0BBAAAA
|
Isotrex | Isotretinoin | Skin | No data available |
|
Roaccutane 5mg capsules
1306020J0BBAAAA
|
Roaccutane | Isotretinoin | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.